Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

被引：0
|
作者：
Dana J. Holger
Nicholas S. Rebold
Sara Alosaimy
Taylor Morrisette
Abdalhamid Lagnf
Ana Christine Belza
Ashlan J. Kunz Coyne
Amer El Ghali
Michael P. Veve
Michael J. Rybak
机构：
[1] Wayne State University,Anti
[2] Wayne State University,Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences
[3] Henry Ford Hospital,Department of Pharmacy
[4] Detroit Receiving Hospital,Department of Pharmacy Services
[5] Detroit Medical Center,School of Medicine
[6] Wayne State University,Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy
[7] Seres Therapeutics,Department of Pharmacy Services
[8] Medical University of South Carolina,undefined
[9] Medical University of South Carolina Shawn Jenkins Children’s Hospital,undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
Ceftolozane–tazobactam; HABP/VABP; Multidrug resistance; Pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1965 / 1980
页数：15
相关论文
共 50 条
  • [21] Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy
    Fernandez-Esgueva, Marta
    Isabel Lopez-Calleja, Ana
    Mulet, Xavier
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Huarte, Rafael
    Rezusta, Antonio
    Oliver, Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2020, 38 (10): : 474 - 478
  • [22] Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa
    Xipell, Marc
    Paredes, Sandra
    Fresco, Leticia
    Bodro, Marta
    Marco, Francesc
    Martinez, J. A.
    Soriano, Alex
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 13 : 165 - 170
  • [23] Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa
    Martin-Cazana, Maria
    Grau, Santiago
    Epalza, Cristina
    Branas, Patricia
    Flores, Marta
    Olmedilla, Marta
    Blazquez-Gamero, Daniel
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (08) : 985 - 987
  • [24] Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa
    Pogue, Jason M.
    Kaye, Keith S.
    Veve, Michael P.
    Patel, Twisha S.
    Gerlach, Anthony T.
    Davis, Susan L.
    Puzniak, Laura A.
    File, Tom M.
    Olson, Shannon
    Dhar, Sorabh
    Bonomo, Robert A.
    Perez, Federico
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (02) : 304 - 310
  • [25] Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa
    Abd El-Baky, Rehab M.
    Masoud, Salwa M.
    Mohamed, Doaa S.
    Waly, Nancy G. F. M.
    Shafik, Engy A.
    Mohareb, Dina A.
    Elkady, Azza
    Elbadr, Mohamed M.
    Hetta, Helal F.
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 323 - 332
  • [26] The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
    Reynolds, Daniel
    Burnham, Jason P.
    Guillamet, Cristina Vazquez
    McCabe, Mikaela
    Yuenger, Valerie
    Betthauser, Kevin
    Micek, Scott T.
    Kollef, Marin H.
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166):
  • [27] Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa
    Mogyorodi, Bence
    Cseko, Andras B.
    Hermann, Csaba
    Gal, Janos
    Ivanyi, Zsolt D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa
    Bence Mogyoródi
    András B. Csékó
    Csaba Hermann
    János Gál
    Zsolt D. Iványi
    Scientific Reports, 12
  • [29] Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
    Marianna Meschiari
    Iacopo Franconi
    Erica Bacca
    Vincenzo Bianco
    Gabriella Orlando
    Gianluca Cuomo
    Andrea Bedini
    Cristina Mussini
    Infection, 2021, 49 : 549 - 553
  • [30] Outpatient Parenteral Antimicrobial Therapy With Ceftolozane/Tazobactam via Continuous Infusion for Multidrug-Resistant Pseudomonas aeruginosa Osteomyelitis
    Alvarez Otero, Judith
    Lamas Ferreiro, Jose Luis
    Sanjurjo Rivo, Ana
    de la Fuente Aguado, Javier
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):
12345